Sentry Investment Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,344
Closed -$23K 507
2023
Q3
$23K Sell
1,344
-325
-19% -$6.78K 0.01% 502
2023
Q2
$35K Hold
1,669
0.01% 491
2023
Q1
$39K Buy
+1,669
New +$44.8K 0.02% 456
2022
Q4
Sell
-1,624
Closed -$38K 516
2022
Q3
$38K Hold
1,624
0.02% 507
2022
Q2
$55K Sell
1,624
-316
-16% -$11.1K 0.02% 464
2022
Q1
$68K Sell
1,940
-326
-14% -$11.1K 0.02% 481
2021
Q4
$69K Hold
2,266
0.02% 460
2021
Q3
$74K Sell
2,266
-331
-13% -$10.6K 0.02% 469
2021
Q2
$79K Buy
+2,597
New +$85.5K 0.02% 433

Other funds holding OGN

Sentry Investment Management's OGN Position: Q4 2023 in Review

Sentry Investment Management sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 1,344 shares — an estimated $23K sold.

Sentry Investment Management first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $79K in Q2 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

  • Sentry Investment Management reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
  • Sentry Investment Management sold 1,344 Organon & Co shares in Q4 2023, an estimated $23K.
  • Sentry Investment Management first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
  • Sentry Investment Management's Organon & Co position peaked at $79K in Q2 2021.
  • 719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Sentry Investment Management's 13F filing for Q4 2023, filed 30 Jan 2024.